Skip to main content
. 2015 Apr 22;101(6):1206–1215. doi: 10.3945/ajcn.114.096016

TABLE 5.

ORs (95% CIs) for the joint effect of serum DBP and serum 25(OH)D and risk of pancreatic cancer in 295 cases and 587 controls1

Serum 25(OH)D
<50.0 nmol/L ≥50.0 to <75.0 nmol/L ≥75.0 nmol/L P-trend P-interaction2
Multivariable-adjusted OR3 (95% CI) (n = 295/587) 0.12
 Cases/controls, n/n 62/96 45/125 39/72
  DBP less than median 2.05 (1.06, 3.98)* 1.00 (reference) 1.60 (0.82, 3.11) 0.63
 Cases/controls, n/n 41/70 60/129 48/95
  DBP of median or greater 1.27 (0.65, 2.47) 1.31 (0.71, 2.39) 2.08 (1.08, 4.00)* 0.11
Lag analysis for cases diagnosed >5 y after baseline3 (n = 214/428) 0.04
 Cases/controls, n/n 46/71 26/84 32/64
  DBP less than median 2.28 (1.04, 5.00)* 1.00 (reference) 1.88 (0.86, 4.10) 0.87
 Cases/controls, n/n 28/59 44/92 38/58
  DBP of median or greater 1.17 (0.54, 2.55) 1.43 (0.69, 2.96) 3.19 (1.44, 7.09)*4 0.02*
1

A chi-square test of the association between the joint variable [DBP and 25(OH)D combined status] and case status produced a P value of 0.21. Multivariable and lag analysis ORs and 95% CIs were calculated by using conditional logistic regression, conditioned on matched variables (age, race-ethnicity, sex, month of blood draw) and adjusted for smoking status (never; former, ≥15 y; former, <15 y; current) and self-reported diabetes (yes or no). *Significant. DBP, vitamin D–binding protein; 25(OH)D, 25-hydroxyvitamin D.

2

Based on clinically relevant 25(OH)D cutoffs and median split DBP.

3

The median DBP is 5358.19 nmol/L.

4

Significant at the Bonferroni-corrected P value, 0.05/2 = 0.025.